These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12110035)

  • 21. Development of toxic degradation products during heat sterilization of glucose-containing fluids for peritoneal dialysis: influence of time and temperature.
    Kjellstrand P; Martinson E; Wieslander A; Holmquist B
    Perit Dial Int; 1995; 15(1):26-32. PubMed ID: 7734557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid.
    Ishikawa N; Miyata T; Ueda Y; Inagi R; Izuhara Y; Yuzawa H; Onogi H; Nishina M; Nangaku M; Van Ypersele De Strihou C; Kurokawa K
    Kidney Int; 2003 Jan; 63(1):331-9. PubMed ID: 12472800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological significance of reducing glucose degradation products in peritoneal dialysis fluids.
    Wieslander A; Linden T; Musi B; Carlsson O; Deppisch R
    Perit Dial Int; 2000; 20 Suppl 5():S23-7. PubMed ID: 11229608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicity of effluent peritoneal dialysis fluid.
    Wieslander AP; Andrén A; Martinson E; Kjellstrand P; Hultqvist M
    Adv Perit Dial; 1993; 9():31-5. PubMed ID: 8105952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxicity, pH, and glucose degradation products in four different brands of PD fluid.
    Wieslander A; Forsbäck G; Svensson E; Lindén T
    Adv Perit Dial; 1996; 12():57-60. PubMed ID: 8865874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicity of heat sterilized peritoneal dialysis fluids is derived from degradation of glucose.
    Martinson E; Wieslander A; Kjellstrand P; Boberg U
    ASAIO J; 1992; 38(3):M370-2. PubMed ID: 1457884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trans-3,4-dideoxyglucone-3-ene (trans-3,4-DGE), a most reactive glucose degradation product in freshly heat sterilized glucose solutions.
    Chen K; Prabel J; Dutton J; Gotoda M; Asai Y; Grobin A
    Carbohydr Res; 2015 Dec; 418():57-64. PubMed ID: 26546740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization.
    Santamaría B; Ucero AC; Reyero A; Selgas R; Ruiz-Ortega M; Catalán M; Egido J; Ortiz A
    Nephrol Dial Transplant; 2008 Oct; 23(10):3307-15. PubMed ID: 18524790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
    Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
    Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose degradation products in peritoneal dialysis fluids may have both local and systemic effects: a study of residual fluid and mesothelial cells.
    Linden T; Musi B; Järkelid L; Forsbäck G; Kjellstrand P; Deppisch R; Wieslander A
    Perit Dial Int; 2001; 21(6):607-10. PubMed ID: 11783771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient in vitro lowering of carbonyl stress by the glyoxalase system in conventional glucose peritoneal dialysis fluid.
    Inagi R; Miyata T; Ueda Y; Yoshino A; Nangaku M; van Ypersele de Strihou C; Kurokawa K
    Kidney Int; 2002 Aug; 62(2):679-87. PubMed ID: 12110033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids.
    Schalkwijk CG; Posthuma N; ten Brink HJ; ter Wee PM; Teerlink T
    Perit Dial Int; 1999; 19(4):325-33. PubMed ID: 10507813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis.
    Wieslander AP; Deppisch R; Svensson E; Forsbäck G; Speidel R; Rippe B
    Perit Dial Int; 1995; 15(2):158-64. PubMed ID: 7612737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peritoneal fibrosis and high transport are induced in mildly pre-injured peritoneum by 3,4-dideoxyglucosone-3-ene in mice.
    Yokoi H; Kasahara M; Mori K; Kuwabara T; Toda N; Yamada R; Namoto S; Yamamoto T; Seki N; Souma N; Yamaguchi T; Sugawara A; Mukoyama M; Nakao K
    Perit Dial Int; 2013; 33(2):143-54. PubMed ID: 23123666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis.
    Catalan MP; Santamaría B; Reyero A; Ortiz A; Egido J; Ortiz A
    Kidney Int; 2005 Sep; 68(3):1303-11. PubMed ID: 16105065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis.
    Linden T; Forsbäck G; Deppisch R; Henle T; Wieslander A
    Perit Dial Int; 1998; 18(3):290-3. PubMed ID: 9663893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heat sterilized PD-fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes.
    Wieslander AP; Nordin MK; Martinson E; Kjellstrand PT; Boberg UC
    Clin Nephrol; 1993 Jun; 39(6):343-8. PubMed ID: 8392917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid and reliable measurement for evaluating directly the reactivity of N-acetylcysteine with glucose degradation products in peritoneal dialysis fluids.
    Lee E; Seo EY; Kwon Y; Ha H
    Anal Chem; 2011 Mar; 83(5):1518-22. PubMed ID: 21299245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heat sterilization of peritoneal dialysis solutions influences ingestive behavior in non-uremic rats.
    Zheng ZH; Anderstam B; Qureshi AR; Heimbürger O; Wang T; Södersten P; Bergström J; Lindholm B
    Kidney Int; 2002 Oct; 62(4):1447-53. PubMed ID: 12234318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of [6-Hydroxy-2-(hydroxymethyl)-5-oxo-5,6-dihydro-2 H-pyran-3-yl]-cysteine (HHPC) as a Cysteine-specific Modification Formed from 3,4-Dideoxyglucosone-3-ene (3,4-DGE).
    Gensberger-Reigl S; Atzenbeck L; Göttler A; Pischetsrieder M
    Chem Res Toxicol; 2019 Feb; 32(2):304-311. PubMed ID: 30640474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.